Empowered Funds
NGNE icon

Empowered Funds’s Neurogene NGNE Stock Holding History

Empowered Funds’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$349K Buy
+12,551
New +$447K ﹤0.01% 1970

Other funds holding NGNE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Tyro Capital Management
Tyro Capital Management Miami, Florida $564M AUM 72.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JHC
Jones Hill Capital New York $589M AUM

Empowered Funds's NGNE Position: Q3 2026 in Review

Empowered Funds opened a new position in Neurogene (NGNE) in Q3 2026: 12,551 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #1970 among its holdings.

80 funds tracked by Wall St. Rank hold NGNE as of Q3 2026.

  • Empowered Funds held 12,551 shares of Neurogene worth $349K as of Q3 2026.
  • Neurogene was a new Empowered Funds position in Q3 2026.
  • Neurogene made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #1970 holding.
  • 80 funds tracked by Wall St. Rank held Neurogene as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.